INOVA Diagnostics stands for INNOVATION. Throughout our history we have strived to collaborate with the best autoimmune disease scientists throughout the world. This has allowed INOVA Diagnostics to be at the forefront of commercialized autoimmune diagnostics research and development. We are proud of the cutting-edge diagnostics products our research and development groups have been able to develop for our customers. Below you will find a sampling of the scientific posters that have been presented at various meetings arranged by disease state.
Liver | Connective Tissue Disease | Gastrointestinal | Hepatocellular Carcinoma | Rheumatoid Arthritis | Vasculitis |
Anti-phospholipid Syndrome
ANTI-SS-A/Ro 52 AUTOANTIBODIES ARE NOT PART OF THE ORIGINALLY DEFINED ANTI SS A/Ro REACTIVITY
R. W. Burlingame1, A. L. Piette1, C. Peebles1, T. Webb1, C. A. von Mühlen2, R. C. Williams, Jr.3, M. Fritzler4, P. Charles5, K.M. Pollard6, N. Fertig7, C. Watkins7 and C. Oddis7; 1INOVA Diagnostics, Inc., San Diego, CA USA; 2PUCSchool of Medicine, Porto Alegre, Brazil; 3University of New Mexico School of Medicine, Albuquerque, USA; 4Univeristy of Calgary, Calgary, Canada; 5Kennedy Institute of Rheumatology, London, UK; 6The Scripps Research Institute, La Jolla, USA; 7University of Pittsburgh School of Medicine, Pittsburgh, USA
THE PM/DM 4 ELISA, A TEST THAT IS TWICE AS SENSITIVE AS Jo 1 FOR AUTOANTIBODIES IN PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS
Tyler T. Webb1, Noreen Fertig2, Chester V. Oddis2, Peter Charles3 and Rufus W. Burlingame1, 1INOVA Diagnostics, Inc., San Diego, CA; 2University of Pittsburgh School of Medicine, Pittsburgh, PA; 3Hammersmith Hospitals NHS Trust, London, UK
VERY HIGH DIAGNOSTIC AND PROGNOSTIC UTILITY OF A SIMPLE ELISA TO MEASURE ANTI-RNA-POLYMERASE III AUTOANTIBODIES
Tyler T. Webb1, Todd S. Parker1, Noreen Fertig2, Thomas A. Medsger2, K. Michael Pollard3, Masataka Kuwana4, Christopher C. Bunn5, Rufus W. Burlingame1 1INOVA Diagnostics, Inc., San Diego, CA; 2University of Pittsburgh School of Medicine, Pittsburgh, PA; 3The Scripps Research Institute, La Jolla, CA; 4Keio University School of Medicine, Tokyo, Japan; 5Royal Free Hospital, London, UK
MULTIPlexED TEST FOR AUTOANTIBODIES TO NUCLEAR ANTIGENS USING THE LUMINEX 100TM
A.L. Piette, W. Binder and R.W. Burlingame, INOVA Diagnostics, Inc., San Diego, CA
THREE MULTIPlexED TESTS FOR EXTRACTABLE NUCLEAR ANTIGENS USING THE LUMINEX 100TM
Rufus W. Burlingame1, Andrea L. Piette1, Carlos von Mohlen2, K. Michael Pollard3 and Walter L. Binder1, 1INOVA Diagnostics, Inc., San Diego, CA; 2PUC School of Medicine, Porto Alegre, Brazil; 3The Scripps Research Institute, La Jolla, CA
THE CLINICAL UTILITY OF ANTI-CHROMATIN (ANTI-NUCLEOSOME) IN DIAGNOSING SLE
Rufus W. Burlingame1, Ricard Cervera2, Terry W. Du Clos3, Rene-Louis Humbel4, Carlos von Mühlen5 and Walter Binder1, 1INOVA Diagnostics, Inc., San Diego, CA; 2Hospital Clinic, Barcelona, Catalonia, Spain; 3VA Medical Center, Albuquerque, NM; 4Centre Hospitalier de Luxembourg, Luxembourg; 5PUC School of Medicine, Porto Alegre, Brazil
IMPROVEMENTS IN THE CLINICAL SENSITIVITY OF ANA ELISA TESTING
P. Martis, A.L. Piette, R.W. Burlingame, INOVA Diagnostics, Inc., San Diego, CA